Baseline and on Treatment Biodistribution Variability of 18F-FLT Uptake in Patients With Advanced Melanoma: Brief Communication.
Bernies van der HielElse A AalbersbergAlfonsus J M van den EertweghJitha FischerRonald BoellaardFilip Yves Francine De VosMarye J Boers-SonderenMarcel P M StokkelBerlinda Jantina de Wit-van der VeenJohn B A G HaanenPublished in: Clinical nuclear medicine (2024)
To assess 18F-FLT PET, both liver and bone marrow uptake may be used as normal tissue references at baseline, but 18F-FLT biodistribution significantly changes in longitudinal response studies when treated with BRAF/MEK inhibitors.